Recruiting
Phase 1

Glycemic Effect of Diazoxide in NAFLD

Sponsor:

Columbia University

Code:

NCT05729282

Conditions

Hyperinsulinemia

Insulin Resistance

Non-Alcoholic Fatty Liver Disease

Prediabetic State

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Diazoxide oral suspension, 1 mg per kg per dose

Diazoxide oral suspension, 2 mg per kg per dose

Placebo

FreeStyle Libre Pro

Deuterated water (2H2O/D2O)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information